New Zealand Update – The domestic medicinal cannabis sector in New Zealand is grappling with significant regulatory constraints, making local market access difficult for businesses. This forces even successful operators like Blenheim-based grower Puro to focus entirely on exports.

In a striking example, Puro has just signed an NZD $16 million contract to export its organic medicinal cannabis products to the UK – a global record. Yet, ironically, the company struggles to supply the New Zealand market directly.

Packaging Woes and the Overseas Pull
Puro co-founder Tim Aldridge highlights the complexity and cost burden of domestic regulations. A key inefficiency is the requirement for products to be shipped to Australia for packaging before being re-imported to New Zealand for sale, significantly increasing time and expense. This stands in stark contrast to the simpler, more attractive export pathway.

The Core Issue: NZs Medicinal Cannabis Scheme
This dilemma stems from New Zealands strict regulatory framework, the Medicinal Cannabis Scheme, introduced in 2019 after industry consultation to ensure patient safety and product quality. Its cornerstone requirement is that all medicinal cannabis products sold domestically must meet Pharmaceutical Good Manufacturing Practice (GMP) standards, which include mandatory processes like irradiation.

This creates several problems:

1. Standard Disparity: Products for export only need to meet the Good Agricultural and Collection Practice (GACP) standard, focused primarily on cultivation. This is the standard Puro meets for its exports and is significantly less costly than GMP.

2. High Domestic Barriers: Sally King, Executive Director of the NZ Medical Cannabis Council, explains the domestic hurdles:Split Licensing: Businesses need separate licenses for cultivation, manufacturing, and sales.Complex Process: Local products cannot move directly from grower to pharmacy (e.g., as cannabis flower). They must undergo additional GMP-standard packaging and processing, further inflating costs.Stringent Rules: Every step, from cultivation (strict rules on plants, environment, nutrients) to manufacturing, is heavily regulated.

Navigating Licenses: GACP vs. GMP
The path forward depends heavily on the target market:

1. Define Market: Choose export (GACP focus) or domestic (GMP focus). Domestic currently presents much higher hurdles.

2. Identify Licenses:Cultivation License (GACP): For growing, detailing plans, facilities, security, environmental controls, and pest management.Manufacturing License (GMP): Essential for domestic sales. Allows processing, extraction, formulation, and crucially, packaging to GMP standards. This demands expensive facilities, rigorous quality control labs, validated processes, and extensive documentation (including irradiation).Sales License: For distributing final products domestically.

3. Meet the Standards:GACP (Export/Raw Material): Focuses on standardized, traceable cultivation, environmental control, safety, and clean materials. Requires detailed SOPs.GMP (Domestic Sales): Demands high-cost infrastructure, full QC labs, validated processes, and strict documentation.

4. Consult Regulators: Despite attempts by figures like Aldridge to engage the Ministry for Regulation and Ministry of Health to simplify rules (like domestic packaging), changes require legislation. Applicants should thoroughly study Medicinal Cannabis Agency (MCA) guidelines and engage in pre-application meetings. Note: Some CBD rules eased slightly from October 2024, but the THC framework remains strict.

5. High Cost Reality: GMP compliance is the major barrier to domestic sales, drastically increasing product costs (the primary reason for high local prices, according to King). The application process itself is costly and time-consuming.

6. Assess Export Viability: Given domestic barriers, Puros success demonstrates that focusing on GACP-compliant cultivation for export of raw material or bulk product is currently a more practical, lower-barrier option with faster market access.

Packaging Innovation Contrast: The Silver Tin Can
Amidst these complex packaging requirements for the domestic market, a contrasting innovation highlights simplicity elsewhere: The Silver tin can. This unique container can be sealed at home with only your hands! After the ring has been pulled, the tin can can then be re-sealed with the plastic cap, to keep your product fresh! Available with black, clear, or white plastic lid caps, such cans are versatile for storing food, essentials, organizing items, medication, herbs, spices, seasonings, party favors, or product samples. They keep contents protected from high temperatures and even body heat when stored in a pocket.

Future Outlook
Sally King remains optimistic about potential future simplifications to domestic regulations, such as adopting GACP as the local cultivation standard. However, she emphasizes this requires significant political will and recognition by regulators and politicians of the opportunity, alongside careful risk management. Until then, the path of least resistance, and greatest opportunity, for New Zealand growers like Puro, continues to lead overseas.